Most people need exactly two shots of the shingles vaccine Shingrix, spaced a few months apart, and that is currently the entire series. No booster dose is recommended at this time. The two-dose schedule applies to the vast majority of adults, though the timing between doses and the age you become eligible depend on your immune status. The picture gets more interesting when you factor in how long protection lasts, what happens if you got the older vaccine years ago, and whether the science points toward a booster down the road.
The Standard Two-Dose Schedule
The CDC recommends two doses of Shingrix, separated by two to six months, for immunocompetent adults aged 50 and older.1CDC. Shingles Vaccine Recommendations – Section: Routine recommendations That means you get the first shot, wait at least two months, then come back for the second. There is no third dose, no annual booster, and no plan to restart the series at a later age. Two shots, and you are done with the current recommendations.
The reason for two doses rather than one is straightforward: a single shot of Shingrix does provide some protection, but the immune response after two doses is substantially stronger and more durable. The vaccine is a recombinant product paired with an adjuvant designed to kick the immune system into a higher gear. That adjuvant is part of why side effects like sore arm, fatigue, and muscle aches are relatively common after each shot, but it is also why the vaccine works as well as it does. Skipping the second dose leaves you with incomplete protection.
How Long Does Protection Last
This is the question that determines whether “two shots in a lifetime” remains the final answer or eventually becomes “two shots plus a booster.” So far, the data look encouraging. A long-term follow-up study of more than 7,000 participants from the original pivotal trials found that vaccine efficacy against shingles remained around 84% from roughly five to seven years after the two-dose series. Annual efficacy estimates stayed above 84% for each year of follow-up, and both antibody and cellular immune responses plateaued at levels more than six times higher than before vaccination.2Oxford Academic. The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70 – Section: CONCLUSIONS
Seven years of strong protection is good news, but Shingrix was only approved in 2017, so we are still in the window where longer-term data are being collected. The fact that immune responses were not declining at the seven-year mark suggests protection could extend well beyond that. Researchers are continuing to track participants, and updated data at the ten-year mark and beyond will be what ultimately settles the booster question. For now, no health agency recommends a booster dose after the initial two-shot series.
If you are someone who got vaccinated at 50 and is now wondering whether you will need another round at 60 or 65, the honest answer is that nobody knows yet. The trajectory of the data suggests you might not, but the CDC has said it will revisit the question as longer-term evidence accumulates. If a booster is eventually recommended, it would likely be a single additional dose rather than a repeat of the full two-dose series, based on how similar vaccines have been handled in the past. But that is speculation, not policy.
What If You Got the Older Zostavax Vaccine
Before Shingrix arrived, the only shingles vaccine available was Zostavax, a live-attenuated vaccine that was given as a single injection. Zostavax was discontinued in the United States in 2020 and is no longer available. If you received it years ago, you still need both doses of Shingrix. The CDC is clear on this point: you should get Shingrix even if you previously received Zostavax.3CDC. Shingles Vaccination – Section: Who should get vaccinated
Zostavax provided moderate protection that waned substantially over time. Studies showed its efficacy dropped considerably within a few years, especially in older adults. Shingrix is a fundamentally different vaccine with a different mechanism and a much higher efficacy rate, so the prior Zostavax dose does not substitute for either Shingrix shot. Think of it as starting fresh with a better product. The recommended waiting period between a Zostavax dose and starting the Shingrix series is generally at least eight weeks, though most people who received Zostavax got it years ago, so this timing issue rarely comes up anymore.
The Schedule for Immunocompromised Adults
People with weakened immune systems face a higher risk of shingles and tend to get more severe cases when they do. In 2021, the FDA expanded Shingrix’s indication to cover adults aged 18 and older who are or will be immunocompromised due to disease or treatment.4Centers for Disease Control and Prevention. Clinical Considerations for Shingrix Use in Immunocompromised Adults Aged ≥19 Years – Section: Dosing schedule This is a significant difference from the general population, where vaccination starts at age 50.
The number of doses is still two, but the timing can be compressed. For immunocompromised patients who would benefit from completing the series more quickly, the second dose can be given one to two months after the first, rather than the standard two to six months.4Centers for Disease Control and Prevention. Clinical Considerations for Shingrix Use in Immunocompromised Adults Aged ≥19 Years – Section: Dosing schedule This compressed schedule is particularly relevant for people who are about to start chemotherapy, organ transplant immunosuppression, or other treatments that will further compromise their immune systems. Getting both doses in before treatment begins gives the body the best chance to mount a full immune response while it still can.
Conditions and treatments that qualify someone for earlier vaccination include HIV, certain cancers and blood cancers, stem cell or solid organ transplant, and medications like high-dose corticosteroids, biologics, or chemotherapy agents. If you are under 50 and taking any immunosuppressive medication, it is worth asking your doctor whether you qualify.
What Happens If You Miss the Second Dose Window
Life gets in the way. Maybe you got the first shot and then moved, changed insurance, got busy, or simply forgot. The good news is that even if you have gone well past the recommended two-to-six-month window, you do not need to start over. The CDC’s guidance is to get the second dose as soon as possible without restarting the series.5Centers for Disease Control and Prevention. Shingles Vaccine Recommendations – Section: Routine recommendations
This is a common concern, and it applies to many vaccine series, not just Shingrix. The immune system’s memory from the first dose does not simply vanish after six months. A late second dose will still serve as an effective booster to that initial immune priming. The issue with waiting too long is not that you lose the benefit of the first shot entirely, but that you are walking around with incomplete protection in the meantime. So if you are a year or even two years overdue for your second Shingrix dose, schedule it now. You will still end up with strong immunity from the completed series.
Do You Need Shingrix If You Already Had Shingles
Yes. Having had shingles does not protect you from getting it again, and the CDC recommends Shingrix for people who have already had a shingles episode.3CDC. Shingles Vaccination – Section: Who should get vaccinated Recurrence is not uncommon, and a second episode can be just as painful as the first, sometimes more so. The varicella-zoster virus remains dormant in your nerve cells after the initial shingles attack, and it can reactivate again.
Most doctors suggest waiting until the acute shingles rash has fully resolved before starting the Shingrix series. There is no strict guideline on exactly how long to wait after an episode, but a general rule of thumb is to let the rash clear completely. Some providers suggest waiting a few months to allow the acute immune response to settle, though this is a clinical judgment call rather than a rigid requirement.
The same logic applies if you had chickenpox as a child, which is the initial infection with the same virus that causes shingles. Nearly all adults born before 1980 in the United States carry the varicella-zoster virus and are candidates for Shingrix at age 50. Even adults who received the chickenpox vaccine rather than having natural infection should get Shingrix when they reach the recommended age, since the vaccine virus can also reactivate, though this is less common.3CDC. Shingles Vaccination – Section: Who should get vaccinated
Why the Two-Dose Requirement Trips People Up
Shingrix has a well-documented completion problem. A meaningful percentage of people who get the first dose never come back for the second. Some of this is logistical: Shingrix has experienced periodic supply shortages since its launch, and early on, many people who received dose one found that dose two simply was not available when they returned. Others forget, or they had a rough reaction to the first shot and feel reluctant to go through it again.
The side effects are worth addressing directly, because they are a genuine reason people skip the second dose. Shingrix is more reactogenic than many vaccines adults are used to. Sore arm, fatigue, headache, muscle pain, and sometimes fever are all common in the first few days after each injection. These symptoms are temporary and typically resolve within two to three days. They are signs that the immune system is responding to the adjuvant, and they do not indicate anything harmful. But when someone felt genuinely lousy for a day or two after dose one, the prospect of voluntarily doing that again can be a hard sell.
The counterargument is straightforward: shingles itself is vastly worse than any vaccine side effect. The hallmark complication, postherpetic neuralgia, involves nerve pain that can last months or even years after the rash clears. It can be debilitating, resistant to treatment, and profoundly disruptive to daily life. The risk of postherpetic neuralgia rises sharply with age, which is exactly the population Shingrix targets. A couple of uncomfortable days after a vaccine is a small price compared to the potential for months of nerve pain.
Cost and Access Considerations
Shingrix is not cheap. Without insurance, each dose runs in the range of $150 to $200, putting the two-dose series somewhere around $300 to $400 out of pocket. For adults 50 and older with Medicare Part D or commercial insurance, Shingrix is typically covered, though you may face a copay depending on your plan. The Inflation Reduction Act eliminated cost-sharing for recommended vaccines under Medicare Part D starting in 2023, which means most Medicare beneficiaries can now get Shingrix at no cost.
For immunocompromised adults between 19 and 49 who qualify for earlier vaccination, insurance coverage can be more variable. Some plans cover it without issue once a provider documents the medical need, while others may require prior authorization. If you are in this younger age group and facing a coverage denial, your doctor’s office can often help with an appeal by providing documentation of your immunocompromising condition.
Shingrix is available at most pharmacies, including chain drugstores and grocery store pharmacies, as well as at doctor’s offices. You generally do not need a prescription to get it at a pharmacy, though the pharmacist will confirm your age and eligibility. Scheduling both doses through the same pharmacy makes it easier to stay on track, since many pharmacies will send reminders when your second dose is due.
Who Should Not Get Shingrix
The list of people who should avoid the vaccine entirely is short. If you had a severe allergic reaction to a previous dose of Shingrix or to any component of the vaccine, you should not receive it. People who are currently experiencing an acute episode of shingles should wait until the infection resolves. Pregnant individuals should delay vaccination, as the vaccine has not been studied in pregnancy.
People sometimes ask whether they can get Shingrix at the same visit as other vaccines, like the flu shot or a COVID booster. The answer is generally yes. Shingrix can be co-administered with other vaccines at different injection sites. You may experience more soreness from having two shots in one visit, but it does not reduce the effectiveness of either vaccine. This can be a practical way to stay on schedule if you are already at the pharmacy for another vaccination.
One persistent myth is that you should wait until you are “older” to get Shingrix so the protection covers you during your highest-risk years. This sounds logical on the surface, but it ignores the fact that shingles risk starts climbing well before age 65 or 70, and the vaccine works best when given to a robust immune system. Delaying vaccination means spending additional unprotected years at meaningful risk. With efficacy remaining strong for at least seven years and likely longer, getting vaccinated at 50 does not leave you unprotected in your later decades based on what the data currently show.2Oxford Academic. The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70 – Section: CONCLUSIONS